283 related articles for article (PubMed ID: 11035994)
1. Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors.
Nowak RA
Environ Health Perspect; 2000 Oct; 108 Suppl 5():849-53. PubMed ID: 11035994
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium.
Mangrulkar RS; Ono M; Ishikawa M; Takashima S; Klagsbrun M; Nowak RA
Biol Reprod; 1995 Sep; 53(3):636-46. PubMed ID: 7578688
[TBL] [Abstract][Full Text] [Related]
3. The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cells.
Grudzien MM; Low PS; Manning PC; Arredondo M; Belton RJ; Nowak RA
Fertil Steril; 2010 Mar; 93(4):1290-8. PubMed ID: 19135664
[TBL] [Abstract][Full Text] [Related]
4. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
5. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium.
Dixon D; He H; Haseman JK
Environ Health Perspect; 2000 Oct; 108 Suppl 5():795-802. PubMed ID: 11035985
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of tumor necrosis factor-α on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells.
Wang Y; Feng G; Wang J; Zhou Y; Liu Y; Shi Y; Zhu Y; Lin W; Xu Y; Li Z
Hum Reprod; 2015 Jan; 30(1):61-70. PubMed ID: 25398968
[TBL] [Abstract][Full Text] [Related]
8. Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production.
Lee BS; Margolin SB; Nowak RA
J Clin Endocrinol Metab; 1998 Jan; 83(1):219-23. PubMed ID: 9435445
[TBL] [Abstract][Full Text] [Related]
9. Etiology, diagnosis, and management of uterine leiomyomas.
Rice KE; Secrist JR; Woodrow EL; Hallock LM; Neal JL
J Midwifery Womens Health; 2012; 57(3):241-7. PubMed ID: 22587581
[TBL] [Abstract][Full Text] [Related]
10. Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.
Koohestani F; Qiang W; MacNeill AL; Druschitz SA; Serna VA; Adur M; Kurita T; Nowak RA
Hum Reprod; 2016 Jul; 31(7):1540-51. PubMed ID: 27130615
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha is a potent inhibitor of basic fibroblast growth factor-stimulated cell proliferation in human uterine cells.
Lee BS; Stewart EA; Sahakian M; Nowak RA
Am J Reprod Immunol; 1998 Jul; 40(1):19-25. PubMed ID: 9689356
[TBL] [Abstract][Full Text] [Related]
13. Medical treatment of uterine leiomyoma.
Sabry M; Al-Hendy A
Reprod Sci; 2012 Apr; 19(4):339-53. PubMed ID: 22378865
[TBL] [Abstract][Full Text] [Related]
14. Validation of the aging hen (Gallus gallus domesticus) as an animal model for uterine leiomyomas.
Machado SA; Bahr JM; Hales DB; Braundmeier AG; Quade BJ; Nowak RA
Biol Reprod; 2012 Oct; 87(4):86. PubMed ID: 22811571
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle.
Zhou Y; Ren Y; Cui L; Li Z; Zhu Y; Lin W; Wang Y
Am J Obstet Gynecol; 2014 Nov; 211(5):496.e1-496.e13. PubMed ID: 24909339
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of G-protein-coupled estrogen receptor-30 in human myometrial and uterine leiomyoma smooth muscle.
Tian R; Wang Z; Shi Z; Li D; Wang Y; Zhu Y; Lin W; Gui Y; Zheng XL
Fertil Steril; 2013 Jan; 99(1):256-263.e3. PubMed ID: 23043685
[TBL] [Abstract][Full Text] [Related]
17. Fibroids: pathophysiology and current medical treatment.
Nowak RA
Baillieres Best Pract Res Clin Obstet Gynaecol; 1999 Jun; 13(2):223-38. PubMed ID: 10755039
[TBL] [Abstract][Full Text] [Related]
18. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
19. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.
Hague S; Zhang L; Oehler MK; Manek S; MacKenzie IZ; Bicknell R; Rees MC
Clin Cancer Res; 2000 Jul; 6(7):2808-14. PubMed ID: 10914728
[TBL] [Abstract][Full Text] [Related]
20. Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.
Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Chakravarti D; Kim JJ; Wei JJ; Bulun SE
Hum Reprod Update; 2015; 21(1):1-12. PubMed ID: 25205766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
